Vor Biopharma Inc.

NASDAQ:VOR

Biotechnology

Healthcare
$18.18 -2.26%

-$0.34 today

Market cap
$985.10M
Beta
1.73
P/E (TTM)
-0.0
EPS (TTM)
-$2,053.13
52W Low $4.28High $65.80

Volume 0.83M

Average 1.07M

VOR Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How VOR compares with its peers on the latest reported figures

VOR Competitors Peer median
Net Margin for VOR and competitors
Company Period LTM level YoY 3-year change
IPSCCentury Therapeutics, Inc.FY2025-8.8% +1912.1 pp+2509.6 pp
EDITEditas Medicine, Inc.LTM Mar 2026-281.6% +419.5 pp+723.2 pp
AUTLAutolus Therapeutics plcLTM Mar 2026-312.0% +2330.7 pp+2021.6 pp
NTLAIntellia Therapeutics, Inc.LTM Mar 2026-597.0% +557.1 pp+299.9 pp
CRSPCRISPR Therapeutics AGLTM Sep 2026-1812.1% -515.0 pp+132552.9 pp
FATEFate Therapeutics, Inc.LTM Mar 2026-2056.8% -737.9 pp-1758.5 pp
VORVor Biopharma Inc.FY2025— ——
SANASana Biotechnology, Inc.FY2025— ——
RCKTRocket Pharmaceuticals, Inc.FY2025— ——
NKTXNkarta, Inc.FY2025— ——
Peer median (excluding VOR) -454.5%+488.3 pp+1372.4 pp

Competitors are the stored peer set for VOR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue08.96M3.49M00
Gross Profit0(8.96M)(3.49M)00
Gross Margin—————
Research & Development47.53M64.55M94.32M93.31M321.53M
Selling, General & Admin21.49M19.91M31.72M27.88M50.11M
Operating Expenses69.02M84.46M122.54M121.19M371.64M
Depreciation & Amortization1.43M8.96M3.49M3.53M2.89M
EBITDA(67.47M)(83.13M)(114.37M)(113.39M)(693.09M)
EBITDA Margin—————
Operating Income(69.02M)(93.42M)(126.04M)(121.19M)(371.64M)
Operating Margin—————
Interest Income119K1.32M8.17M4.27M5.87M
Interest Expense00000
Other Income / Expenses119K1.32M8.17M4.27M(324.34M)
Income Before Tax(68.9M)(92.09M)(117.86M)(116.91M)(695.98M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(68.9M)(92.09M)(117.86M)(116.91M)(695.98M)
Net Margin—————
EPS (Basic)(37.80)(46.60)(35.00)(34.00)(70.50)
EPS (Diluted)(37.80)(46.60)(35.00)(34.00)(70.50)
Weighted Avg Shares1.86M1.98M3.36M3.44M9.87M
Weighted Avg Shares (Diluted)1.86M1.98M3.36M3.44M9.87M

Vor Biopharma Inc.

NASDAQ:VOR

Intrinsic Alpha fair value

Locked

Current Price

$18.18

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.